Soto-Sánchez Jacqueline, Garza-Treviño Gilberto
Section for Postgraduate Studies and Research, Escuela Nacional de Medicina y Homeopatía, Instituto Politécnico Nacional, Guillermo Massieu Helguera #239, Fracc. La Escalera, Ticomán, Ciudad de México 07320, Mexico.
Pharmaceutics. 2024 Sep 24;16(10):1239. doi: 10.3390/pharmaceutics16101239.
Neglected tropical diseases (NTDs), including leishmaniasis, trypanosomiasis, and schistosomiasis, impose a significant public health burden, especially in developing countries. Despite control efforts, treatment remains challenging due to drug resistance and lack of effective therapies. : This study aimed to synthesize the current research on the combination therapy and phytochemical-loaded nanosystems, which have emerged as promising strategies to enhance treatment efficacy and safety. : In the present review, we conducted a systematic search of the literature and identified several phytochemicals that have been employed in this way, with the notable efficacy of reducing the parasite load in the liver and spleen in cases of visceral , as well as lesion size in cutaneous . Furthermore, they have a synergistic effect against rhodesain; reduce inflammation, parasitic load in the myocardium, cardiac hypertrophy, and IL-15 production in ; and affect both mature and immature stages of , resulting in improved outcomes compared to the administration of phytochemicals alone or with conventional drugs. Moreover, the majority of the combinations studied demonstrated enhanced solubility, efficacy, and selectivity, as well as increased immune response and reduced cytotoxicity. : These formulations appear to offer significant therapeutic benefits, although further research is required to validate their clinical efficacy in humans and their potential to improve treatment outcomes in affected populations.
被忽视的热带病(NTDs),包括利什曼病、锥虫病和血吸虫病,给公共卫生带来了沉重负担,尤其是在发展中国家。尽管采取了防控措施,但由于耐药性和缺乏有效治疗方法,治疗仍然具有挑战性。本研究旨在综合当前关于联合疗法和载有植物化学物质的纳米系统的研究,这些已成为提高治疗效果和安全性的有前景的策略。在本综述中,我们对文献进行了系统检索,确定了几种以这种方式使用的植物化学物质,其显著功效包括在内脏利什曼病病例中降低肝脏和脾脏中的寄生虫负荷,以及在皮肤利什曼病中减小病变大小。此外,它们对罗得西亚蛋白酶具有协同作用;减少炎症、心肌中的寄生虫负荷、心脏肥大和布氏锥虫中的白细胞介素 - 15 产生;并影响布氏锥虫的成熟和未成熟阶段,与单独使用植物化学物质或与传统药物联合使用相比,产生了更好的治疗效果。此外,大多数研究的联合用药显示出溶解度、疗效和选择性增强,以及免疫反应增加和细胞毒性降低。这些制剂似乎具有显著的治疗益处,尽管需要进一步研究来验证它们在人体中的临床疗效以及改善受影响人群治疗效果的潜力。